A meta-analysis advocated that GLP1-RAs could exert antidepressant or anxiolytic effects on reducing the depression rating score of −2.09 (95% CI −2.28 – −1.91, p < 0.001) for diabetic patients (Pozzi et al., 2019). This evidence concerns the gene GLP1R and depressive disorder.